Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial (Q27851578)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q37068027)
(Q59647646)
(Q61111386)
(Q16180903)
(Q115365827)
(P304) 687-97
(P407) (Q1860)
(P433) 9742
(P478) 376
(P577) Saturday, August 28, 2010
(P921) (Q974135)
(Q42824827)
(Q412616)
(P1433) (Q939416)
(P1476) "Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial" (language: en)
(P2093) Andrea Feyereislova
Hyun C Chung
Lin Shen
Akira Sawaki
Florian Lordick
Yasushi Omuro
Taroh Satoh
Giuseppe Aprile
Evgeny Kulikov
Julie Hill
Michaela Lehle
Josef Rüschoff
Yoon-Koo Kang
(P2860) (Q29614969)
(Q29619394)
(Q46464172)
(Q31044850)
(Q33313072)
(Q34603290)
(Q37149210)
(Q37142266)
(Q34554455)
(Q29615810)
(Q27824847)
(Q27824766)
(Q53243856)
(Q37240710)
(Q79218019)
(Q29547699)
(Q38440789)
(Q53604465)
(Q33488159)
(Q40613157)
(Q34572233)
(Q46694609)
(Q34608222)
(Q24236634)
(Q31116004)
(Q35770552)
(Q29617440)
(Q43297511)
other details
description scientific article

External Links